A detailed history of Ahrens Investment Partners LLC transactions in Novartis Ag stock. As of the latest transaction made, Ahrens Investment Partners LLC holds 950 shares of NVS stock, worth $98,249. This represents 0.04% of its overall portfolio holdings.

Number of Shares
950
Holding current value
$98,249
% of portfolio
0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 21, 2023

BUY
$80.03 - $92.81 $76,028 - $88,169
950 New
950 $87,000
Q1 2022

Apr 28, 2022

BUY
$80.11 - $90.62 $160 - $181
2 Added 0.39%
511 $45,000
Q4 2021

Jan 21, 2022

BUY
$79.7 - $88.13 $40,567 - $44,858
509 New
509 $45,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Ahrens Investment Partners LLC Portfolio

Follow Ahrens Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ahrens Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ahrens Investment Partners LLC with notifications on news.